PT Darya-Varia Laboratoria Tbk (DVLA.JK)
IDR 1625.0
(-1.52%)
IDR 1625.0
(-1.52%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1890.88 Billion IDR | -1.36% |
| 2022 | 1917.04 Billion IDR | 0.85% |
| 2021 | 1900.89 Billion IDR | 3.89% |
| 2020 | 1829.69 Billion IDR | 0.92% |
| 2019 | 1813.02 Billion IDR | 6.67% |
| 2018 | 1699.65 Billion IDR | 7.87% |
| 2017 | 1575.64 Billion IDR | 8.56% |
| 2016 | 1451.35 Billion IDR | 11.12% |
| 2015 | 1306.09 Billion IDR | 18.33% |
| 2014 | 1103.82 Billion IDR | 0.19% |
| 2013 | 1101.68 Billion IDR | 1.32% |
| 2012 | 1087.37 Billion IDR | 11.84% |
| 2011 | 972.29 Billion IDR | 4.64% |
| 2010 | 929.19 Billion IDR | 6.91% |
| 2009 | 869.17 Billion IDR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 532.28 Billion IDR | -1.68% |
| 2024 Q3 | 505.44 Billion IDR | -8.92% |
| 2024 Q2 | 554.92 Billion IDR | 4.25% |
| 2023 Q4 | 541.36 Billion IDR | 47.48% |
| 2023 FY | 1890.88 Billion IDR | -1.36% |
| 2023 Q1 | 513.15 Billion IDR | 31.69% |
| 2023 Q2 | 469.27 Billion IDR | -8.55% |
| 2023 Q3 | 367.08 Billion IDR | -21.78% |
| 2022 Q4 | 389.67 Billion IDR | -12.15% |
| 2022 Q1 | 646.25 Billion IDR | 96.09% |
| 2022 Q2 | 437.53 Billion IDR | -32.3% |
| 2022 FY | 1917.04 Billion IDR | 0.85% |
| 2022 Q3 | 443.58 Billion IDR | 1.38% |
| 2021 Q4 | 329.57 Billion IDR | -44.73% |
| 2021 FY | 1900.89 Billion IDR | 3.89% |
| 2021 Q1 | 488.25 Billion IDR | -11.11% |
| 2021 Q2 | 486.8 Billion IDR | -0.3% |
| 2021 Q3 | 596.26 Billion IDR | 22.49% |
| 2020 Q1 | 483.52 Billion IDR | 20.89% |
| 2020 Q4 | 549.26 Billion IDR | 55.88% |
| 2020 Q3 | 352.35 Billion IDR | -20.74% |
| 2020 FY | 1829.69 Billion IDR | 0.92% |
| 2020 Q2 | 444.55 Billion IDR | -8.06% |
| 2019 Q3 | 499.2 Billion IDR | 15.5% |
| 2019 Q1 | 481.63 Billion IDR | 4.22% |
| 2019 Q2 | 432.2 Billion IDR | -10.26% |
| 2019 FY | 1813.02 Billion IDR | 6.67% |
| 2019 Q4 | 399.97 Billion IDR | -19.88% |
| 2018 FY | 1699.65 Billion IDR | 7.87% |
| 2018 Q4 | 462.14 Billion IDR | 9.21% |
| 2018 Q3 | 423.15 Billion IDR | 10.2% |
| 2018 Q2 | 383.98 Billion IDR | -10.78% |
| 2018 Q1 | 430.37 Billion IDR | 19.36% |
| 2017 Q2 | 394.34 Billion IDR | -1.0% |
| 2017 Q3 | 422.42 Billion IDR | 7.12% |
| 2017 Q1 | 398.31 Billion IDR | 32.77% |
| 2017 FY | 1575.64 Billion IDR | 8.56% |
| 2017 Q4 | 360.56 Billion IDR | -14.64% |
| 2016 Q2 | 385.05 Billion IDR | 1.51% |
| 2016 Q4 | 299.99 Billion IDR | -22.48% |
| 2016 FY | 1451.35 Billion IDR | 11.12% |
| 2016 Q1 | 379.31 Billion IDR | 18.11% |
| 2016 Q3 | 386.99 Billion IDR | 0.5% |
| 2015 Q3 | 314.28 Billion IDR | -4.27% |
| 2015 FY | 1306.09 Billion IDR | 18.33% |
| 2015 Q1 | 342.35 Billion IDR | 20.44% |
| 2015 Q2 | 328.29 Billion IDR | -4.11% |
| 2015 Q4 | 321.16 Billion IDR | 2.19% |
| 2014 Q1 | 217.32 Billion IDR | -14.36% |
| 2014 FY | 1103.82 Billion IDR | 0.19% |
| 2014 Q4 | 284.25 Billion IDR | -15.32% |
| 2014 Q3 | 335.66 Billion IDR | 25.91% |
| 2014 Q2 | 266.58 Billion IDR | 22.67% |
| 2013 Q3 | 247.78 Billion IDR | -20.9% |
| 2013 Q1 | 286.87 Billion IDR | 1.96% |
| 2013 FY | 1101.68 Billion IDR | 1.32% |
| 2013 Q4 | 253.75 Billion IDR | 2.41% |
| 2013 Q2 | 313.26 Billion IDR | 9.2% |
| 2012 Q3 | 227.76 Billion IDR | 0.0% |
| 2012 FY | 1087.37 Billion IDR | 11.84% |
| 2012 Q4 | 281.36 Billion IDR | 23.53% |
| 2011 FY | 972.29 Billion IDR | 4.64% |
| 2010 FY | 929.19 Billion IDR | 6.91% |
| 2009 FY | 869.17 Billion IDR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| PT Merck Tbk | 961.43 Billion IDR | -96.674% |
| PT Phapros, Tbk | 1014.12 Billion IDR | -86.454% |
| PT Pyridam Farma Tbk | 702.06 Billion IDR | -169.331% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 3565.93 Billion IDR | 46.974% |
| PT Tempo Scan Pacific Tbk | 13119.78 Billion IDR | 85.588% |